Wide benefits

Personalised medicine - where treatments are tailored individually to patients - and nanotechnology (molecular or atomic scale technology) both have revolutionary commercial potential.

by Knowledge@Wharton, 3 March 2006
Last Updated: 23 Jul 2013

Personalised medicine is said to be closer to yielding widespread benefits, and to a limited extent has already arrived. The treatment of many illnesses, however, remains a process of trial and error: widely prescribed drugs can be ineffective for many people and some even do serious harm. In a world of personalised medicine, doctors could distinguish which patients would benefit from a drug, allowing reductions in unnecessary treatment.

By contrast, nanotechnology comprises a range of micro-technologies. The best-known include fabrics that resist stains and odours through particle combinations. Just $1 billion a year is going into nanotechnology in the US, mainly through start-ups.

Source: Personalised medicine and nanotechnology: trying to bring dreams to market
Knowledge@Wharton, 3 March 2006

Review by Steve Lodge

Find this article useful?

Get more great articles like this in your inbox every lunchtime

Upcoming Events

Subscribe

Get your essential reading delivered. Subscribe to Management Today